TY - JOUR
T1 - Making a SmartStart for peanut introduction to support food allergy prevention guidelines for infants
AU - Vale, Sandra L.
AU - Murray, Kevin
AU - Netting, Merryn J.
AU - O'Sullivan, Michael
AU - Leeb, Alan
AU - Orlemann, Karin
AU - Peters, Ian
AU - Clifford, Rhonda
AU - Campbell, Dianne E.
AU - Salter, Sandra M.
N1 - Funding Information:
SmartStartAllergy was funded by grants from the Australian Government Department of Health and the Perth Children’s Hospital Foundation .
Funding Information:
SmartStartAllergy was funded by grants from the Australian Government Department of Health and the Perth Children's Hospital Foundation.Disclosure of potential conflict of interest: S. L. Vale reports employment by the National Allergy Council (formerly the National Allergy Strategy). D. E. Campbell reports grants from the Westmead Fertility Centre, and Research Grant (principal investigator, collaborator, or consultant; pending and received grants) - National Health and Medical Research Council of Australia, Allergy and Immunology Foundation of Australasia, outside the submitted work. M. J. Netting reports fellowship funding from National Health and Medical Research Council (APP1156518) paid to institution outside the submitted work. M. O'Sullivan reports research grant funding from the Government of Western Australia Department of Health, Raine Medical Research Foundation and Channel 7 Telethon Trust, paid to institution outside the submitted work; a nonremunerated Board Director of the Australasian Society of Clinical Immunology and Allergy. A. Leeb reports that he is a director of SmartVax and a member of AusVaxSafety. D. E. Campbell reports employment with DBV Technologies and honoraria from Allergenis and Nestle Health Sciences outside the submitted work. Netting reports honoraria from Nestle Nutrition Institute, paid to institution outside the submitted work. The rest of the authors declare that they have no relevant conflicts of interest.
Funding Information:
Disclosure of potential conflict of interest: S. L. Vale reports employment by the National Allergy Council (formerly the National Allergy Strategy). D. E. Campbell reports grants from the Westmead Fertility Centre, and Research Grant (principal investigator, collaborator, or consultant; pending and received grants) - National Health and Medical Research Council of Australia, Allergy and Immunology Foundation of Australasia, outside the submitted work. M. J. Netting reports fellowship funding from National Health and Medical Research Council (APP1156518) paid to institution outside the submitted work. M. O’Sullivan reports research grant funding from the Government of Western Australia Department of Health , Raine Medical Research Foundation and Channel 7 Telethon Trust , paid to institution outside the submitted work; a nonremunerated Board Director of the Australasian Society of Clinical Immunology and Allergy . A. Leeb reports that he is a director of SmartVax and a member of AusVaxSafety. D. E. Campbell reports employment with DBV Technologies and honoraria from Allergenis and Nestle Health Sciences outside the submitted work. Netting reports honoraria from Nestle Nutrition Institute, paid to institution outside the submitted work. The rest of the authors declare that they have no relevant conflicts of interest.
Publisher Copyright:
© 2023 The Authors
PY - 2023/8
Y1 - 2023/8
N2 - Background: Food allergy affects up to 10% of Australian infants. It was hypothesized that if parents follow the Australasian Society of Clinical Immunology and Allergy guidelines, Australian food allergy rates may stabilize or decline. Objective: This project aimed to determine whether SmartStartAllergy influenced parental introduction of peanut by age 12 months, including in high-risk infants. Methods: SmartStartAllergy integrates with general practice management software to send text messages to parents via participating general practices. The intervention group participants were sent text messages when their child was aged 6, 9, and 12 months; the control group participants were parents of 12-month-old infants. When their child was aged 12 months, all participants completed a questionnaire regarding eczema and family history of atopy. Infants with severe eczema and/or a family history of atopy were considered high-risk. Results: Between 21 September 2018 and 26 April 2022, a total of 29,092 parents were enrolled in SmartStartAllergy as intervention (n = 18,090) and control (n = 11,002) group members The intervention group was more likely to introduce peanut by 12 months (crude odds ratio = 5.18; P <.0001; 95% CI = 4.35-6.16). After adjustment for the infants’ level of risk and family history of atopy and food allergy, the intervention group was more likely to introduce peanut by 12 months of age (adjusted odds ratio = 5.34; P <.01; 95% CI = 4.48-6.37). Conclusion: SmartStartAllergy appears to be an effective tool for encouraging parental introduction of peanut. The ability to provide parents with credible allergy prevention information, along with the capacity to collect simple responses via text along with additional information via an online questionnaire, make this a useful public health tool.
AB - Background: Food allergy affects up to 10% of Australian infants. It was hypothesized that if parents follow the Australasian Society of Clinical Immunology and Allergy guidelines, Australian food allergy rates may stabilize or decline. Objective: This project aimed to determine whether SmartStartAllergy influenced parental introduction of peanut by age 12 months, including in high-risk infants. Methods: SmartStartAllergy integrates with general practice management software to send text messages to parents via participating general practices. The intervention group participants were sent text messages when their child was aged 6, 9, and 12 months; the control group participants were parents of 12-month-old infants. When their child was aged 12 months, all participants completed a questionnaire regarding eczema and family history of atopy. Infants with severe eczema and/or a family history of atopy were considered high-risk. Results: Between 21 September 2018 and 26 April 2022, a total of 29,092 parents were enrolled in SmartStartAllergy as intervention (n = 18,090) and control (n = 11,002) group members The intervention group was more likely to introduce peanut by 12 months (crude odds ratio = 5.18; P <.0001; 95% CI = 4.35-6.16). After adjustment for the infants’ level of risk and family history of atopy and food allergy, the intervention group was more likely to introduce peanut by 12 months of age (adjusted odds ratio = 5.34; P <.01; 95% CI = 4.48-6.37). Conclusion: SmartStartAllergy appears to be an effective tool for encouraging parental introduction of peanut. The ability to provide parents with credible allergy prevention information, along with the capacity to collect simple responses via text along with additional information via an online questionnaire, make this a useful public health tool.
KW - food allergy
KW - Peanut allergy
KW - prevention
KW - public health intervention
UR - http://www.scopus.com/inward/record.url?scp=85164785360&partnerID=8YFLogxK
U2 - 10.1016/j.jacig.2023.100102
DO - 10.1016/j.jacig.2023.100102
M3 - Article
C2 - 37779522
AN - SCOPUS:85164785360
VL - 2
JO - Journal of Allergy and Clinical Immunology: Global
JF - Journal of Allergy and Clinical Immunology: Global
IS - 3
M1 - 100102
ER -
